Skip to main content
. 2024 Jul 30;30(20):4644–4653. doi: 10.1158/1078-0432.CCR-24-1225

Figure 4.

Figure 4.

HRDsig is superior to BRCAalt alone for enrichment of favorable rwPFS and rwOS. A, rwPFS and (B) rwOS is shown by the cohort subgroup, defined by BRCAalt and/or HRDsig. Interaction P values reflect models containing the two adjacent groups. Full interaction models are available in Supplementary Fig. S8. C, HRDsig detects 21.2% patients who are BRCA-WT and might benefit from mPARPi. D, Bimodal distribution of HRDsig score and overlap with BRCAalt status. tx, therapy.